did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9781846288098

Chlamydia Atherosclerosis Lesion

by
  • ISBN13:

    9781846288098

  • ISBN10:

    1846288096

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2007-09-03
  • Publisher: Springer Verlag

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $199.99 Save up to $163.20
  • Buy Used
    $149.99
    Add to Cart Free Shipping Icon Free Shipping

    USUALLY SHIPS IN 2-4 BUSINESS DAYS

Supplemental Materials

What is included with this book?

Summary

Several viruses, including herpes simplex, cytomegalovirus, and coxsackie B virus, have been implicated in heart disease. Recent work has suggested that atherosclerosis or atheroma - the disease responsible for myocardial infarction, stroke, peripheral vascular and other major vascular problems - is not simply caused by dietary factors but also by Chlamydia pneumoniae infection. This discovery changes the concept of cardiovascular disease, and this will have a profound effect on hundreds of millions of people and is of wide interest to modern cardiovascular medicine.

Author Biography

Dr Allan Shor is an anatomical pathologist who discovered Chlamydia pneumoniae germs in atheroma lesions and described the features of a Chlamydia pneumoniae atheroma lesion of the arteries. He is a world authority of this very specialized field of pathology of Chlamydia pneumoniae and atherosclerosis lesions and possesses a collection of unique and extensive micrographs and electron micrographs of the disease: the result of many years of microscopic and electron microscopic examination of many tens of thousands of atheroma lesions. Dr Allan Shor has written many peer reviewed articles in prominent international journals and given many international invited lectures on the subject.

Table of Contents

Prefacep. vii
Introductionp. 1
Killer Germs That Clog Arteriesp. 1
The Germ's Storyp. 3
A Life of Infection and Destructionp. 3
The Deadly Diseasep. 6
A Very Common Diseasep. 6
A Little Bit of Historyp. 8
Researchp. 10
Cholesterolp. 10
Other Componentsp. 11
Molecular Biology of the Lesionp. 12
The Age of Statisticsp. 12
Animal Studiesp. 13
Modern View of the Lesionp. 13
Atheroma Gruelp. 17
Study of Fatty Gruel That Clogs Arteriesp. 17
Electron Microscopep. 19
Electron Microscopic Features of Atheroma Gruelp. 20
Discoveryp. 29
Does Atheroma Gruel Consist of Fat or Germs?p. 29
Which Germ?p. 30
A Chlamydia Germp. 31
Which Chlamydia Species?p. 35
Some Unique Features of the Chlamydia Germ in Atheromap. 35
Not Conventional Chlamydia Speciesp. 36
A New Chlamydia Speciesp. 37
Other Chlamydia Speciesp. 41
Identification of the Atheroma Germp. 43
Attempts at Identification of the Germp. 43
Positive Identification of Chlamydia TWARp. 45
Methods of Identificationp. 45
Publications, Presentations, and Confirmationp. 48
Publicationsp. 48
Presentationsp. 49
Confirmationp. 50
Possible Special Strain of Chlamydia pneumoniaep. 50
Chlamydia Are Inherent Components of Atheromap. 54
Serology Not Helpfulp. 54
Previous Journal Articles on Atheroma Contain Pictures of Unrecognized Chlamydia Germsp. 55
Persons with Congenital Raised Cholesterol Contain Chlamydia pneumoniae Germs in Atheromap. 56
Are There Other Germs in Atheroma?p. 57
Do Chlamydia Germs Cause Atherosclerosis?p. 60
Determining Causalityp. 60
Statistical Criteriap. 61
Koch's Postulatesp. 62
Does Eradication of Germ Prove Causality?p. 62
No Disease Without Causal Agentp. 63
Pathological Lesion Diagnosisp. 64
Lesion Examinationp. 64
Lesion Diagnosisp. 65
Inability to Diagnose Atheroma Lesionp. 65
Study of Atheroma Lesionsp. 67
Steps in Atheroma Lesion Formationp. 67
Aspects Requiring Reexaminationp. 68
Addressing the Problem of Atheroma Lesion Formationp. 68
New Findings Concerning the Initial Lesionp. 71
Initial Lesionp. 71
Primary Muscle Damagep. 72
Chlamydia Cause Muscle Cell Damagep. 80
Fatty Streak Lesionp. 82
Macrophage Infiltrationp. 82
Macrophages Phagocytose Fat, Germs, and Musclep. 82
Macrophage Reaction Resulting from Germs and Muscle Damagep. 87
Formation of Fibronecrotic Plaquep. 89
Formation of Atheroma Gruelp. 89
Ceroid or Blighted Chlamydia Vacuoles?p. 95
Cholesterol Crystallizationp. 98
Late Sequelae: Fibrosis, Calcification, and Angiogenesisp. 101
Interpretation of Lesionp. 104
Another Way to Look at the Lesionp. 104
Assessment of Evidencep. 109
What Do We Call the Lesion?p. 111
Confirmatory Molecular Biological Studiesp. 112
Is Lymphocytic Infiltrate Caused by Chlamydia?p. 112
Intimal Smooth Muscle Cell Damagep. 113
Monocyte and Macrophage Infiltratep. 113
Endothelial Changesp. 114
Collagen Formationp. 114
Derivation of Lipid in Lesionp. 117
Atheroma Lipidp. 117
Chlamydia Lipidp. 119
Cholesterol: Friend or Foe?p. 121
Acceptancep. 124
Old Ideas Do Not Changep. 124
Rejection of New Ideasp. 125
Diagnosis of Atheroma Lesionsp. 127
Serologyp. 128
Heat Shock Proteinp. 128
C-Reactive Proteinp. 128
Detection of Chlamydia in White Blood Cells and Bloodp. 129
Other Possible Testsp. 129
Pathological Diagnosisp. 129
Chlamydia Inclusion Bodiesp. 129
Electron Microscopyp. 130
Immunohistochemical Detectionp. 130
Polymerase Chain Reactionp. 130
Culturep. 130
Treatmentp. 132
Antibiotic Sensitivityp. 133
What Happens to the Lesion?p. 134
Does the Lesion Change in Size?p. 134
Does the Lesion Change in Character?p. 135
Pathological Studyp. 137
Eradication of Germp. 138
Size of Lesionp. 139
Stage of Lesionp. 139
Decrease in Inflammationp. 139
Fibrosis and Scar Formationp. 139
Regenerationp. 142
Does Treatment Increase Healing?p. 142
Other Studiesp. 144
Animal Studiesp. 144
Retrospective Studiesp. 144
Secondary Prevention Trialsp. 145
Meta-Analysisp. 147
Relevance of Clinical Trialsp. 147
Unconsidered Aspectsp. 147
Noncardiac Treatment Trialsp. 148
What Do We Know About Treatment of Atheroma Lesions?p. 151
Physiology of the Heartp. 151
What Causes a Heart Attack?p. 152
Atherosclerosis Is Not the Same as Ischemic Heart Diseasep. 153
Other Treatment Possibilitiesp. 155
Statinsp. 155
Aspirinp. 156
Antihypertensive Agentsp. 157
New Innovative Agentsp. 157
Immunizationp. 158
Conclusionp. 160
Glossary of Termsp. 161
Indexp. 163
Table of Contents provided by Ingram. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program